An immunohistochemical atlas of necroptotic pathway expression
-
Published:2024-05-15
Issue:7
Volume:16
Page:1717-1749
-
ISSN:1757-4684
-
Container-title:EMBO Molecular Medicine
-
language:en
-
Short-container-title:EMBO Mol Med
Author:
Chiou Shene, Al-Ani Aysha H, Pan YiORCID, Patel Komal M, Kong Isabella Y, Whitehead Lachlan W, Light Amanda, Young Samuel N, Barrios Marilou, Sargeant Callum, Rajasekhar PradeepORCID, Zhu LeahORCID, Hempel Anne, Lin Ann, Rickard James A, Hall Cathrine, Gangatirkar Pradnya, Yip Raymond KHORCID, Cawthorne WayneORCID, Jacobsen Annette VORCID, Horne Christopher R, Martin Katherine RORCID, Ioannidis Lisa JORCID, Hansen Diana SORCID, Day Jessica, Wicks Ian P, Law Charity, Ritchie Matthew E, Bowden Rory, Hildebrand Joanne MORCID, O’Reilly Lorraine AORCID, Silke JohnORCID, Giulino-Roth Lisa, Tsui EllenORCID, Rogers Kelly L, Hawkins Edwin D, Christensen Britt, Murphy James MORCID, Samson André LORCID
Abstract
AbstractNecroptosis is a lytic form of regulated cell death reported to contribute to inflammatory diseases of the gut, skin and lung, as well as ischemic-reperfusion injuries of the kidney, heart and brain. However, precise identification of the cells and tissues that undergo necroptotic cell death in vivo has proven challenging in the absence of robust protocols for immunohistochemical detection. Here, we provide automated immunohistochemistry protocols to detect core necroptosis regulators – Caspase-8, RIPK1, RIPK3 and MLKL – in formalin-fixed mouse and human tissues. We observed surprising heterogeneity in protein expression within tissues, whereby short-lived immune barrier cells were replete with necroptotic effectors, whereas long-lived cells lacked RIPK3 or MLKL expression. Local changes in the expression of necroptotic effectors occurred in response to insults such as inflammation, dysbiosis or immune challenge, consistent with necroptosis being dysregulated in disease contexts. These methods will facilitate the precise localisation and evaluation of necroptotic signaling in vivo.
Funder
DHAC | National Health and Medical Research Council Kenneth Rainin Foundation Avant Foundation Crohn’s and Colitis Australia University of Melbourne
Publisher
Springer Science and Business Media LLC
Reference131 articles.
1. Alvarez-Diaz S, Dillon CP, Lalaoui N, Tanzer MC, Rodriguez DA, Lin A, Lebois M, Hakem R, Josefsson EC, O’Reilly LA et al (2016) The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis. Immunity 45:513–526 2. Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12:205–217 3. Bader SM, Preston SP, Saliba K, Lipszyc A, Grant ZL, Mackiewicz L, Baldi A, Hempel A, Clark MP, Peiris T et al (2023) Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria. Cell Death Differ 30:27–36 4. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300 5. Ben-Moshe S, Shapira Y, Moor AE, Manco R, Veg T, Bahar Halpern K, Itzkovitz S (2019) Spatial sorting enables comprehensive characterization of liver zonation. Nat Metab 1:899–911
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|